# Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial

Study · id `cardio:ct-nct02007837` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02007837](<https://clinicaltrials.gov/study/NCT02007837>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02007837

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 440 participants.

## Technical summary

Registry record NCT02007837. Randomized; quadruple masking; primary purpose prevention. Start 2018-01 (registry gives no type); primary completion 2018-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 440 participants (planned count; ClinicalTrials.gov record NCT02007837, source copy `cardio:ctgov-nct02007837-2016-11-25`, retrieved 2026-10-26)
- Start date: 2018-01 (registry gives no type) (ClinicalTrials.gov record NCT02007837, source copy `cardio:ctgov-nct02007837-2016-11-25`, retrieved 2026-10-26)
- Primary completion: 2018-04 (anticipated) (ClinicalTrials.gov record NCT02007837, source copy `cardio:ctgov-nct02007837-2016-11-25`, retrieved 2026-10-26)
- Completion: 2018-08 (anticipated) (ClinicalTrials.gov record NCT02007837, source copy `cardio:ctgov-nct02007837-2016-11-25`, retrieved 2026-10-26)
- Countries: Ghana (ClinicalTrials.gov record NCT02007837, source copy `cardio:ctgov-nct02007837-2016-11-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02007837-2016-11-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial
- Acronym: 4P
- Condition: Pregnancy Induced Hypertension
- Intervention (Drug): Combined aspirin and multinutrient supplement
- Intervention (Other): Daily text reminder text messages
- Lead sponsor: UMC Utrecht
- Lead sponsor class: OTHER
- Collaborator: Ghana Health Services
- Collaborator class: OTHER\_GOV
- Collaborator: University of Ghana
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: UMC Utrecht (`cardio:org-umc-utrecht`)

## Provenance

Content hash: 87392c67721e5e73b61a8f9b8ecdeb743fa63c168657ed7ecfa524e7d1496885
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
